Characteristic | |
---|---|
Age (years) | 61 ± 10 |
Male sex, n (%) | 44 (62.86) |
Body mass index (kg/m2) | 22 ± 3 |
Left ventricular ejection fraction (%) | 50 |
Cardiac surgery category, n (%) | |
Valve | 37 (52.86) |
CABG | 12 (17.14) |
CABG + valve | 7 (10.00) |
Aortic surgery | 9 (12.86) |
Others | 5 (7.14) |
Postoperative day, n (%) | |
d0 | 62 (88.57%) |
d1 | 8 (11.43%) |
APACHE II scores | 9 ± 5 |
EuroSCORE | 4 ± 2 |
Tidal volume (mL) | 520 ± 28 |
PEEP (cm H2O) | 5 |
PaO2/FiO2 (mmHg) | 123 ± 57 |
Lactate (mmol/L) | 3.23 ± 3.39 |
Patients receiving norepinephrine, n (%) | 45 (64.29) |
Patients receiving dobutamine, n (%) | 9 (12.86) |
Dose of norepinephrine (μg kg−1 min−1) | 0.24 (0.15–0.35) |
Dose of dobutamine (μg kg−1 min−1) | 0.33 (0.28–0.43) |